| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
224,175 |
189,406 |
$24.19M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
221,364 |
192,009 |
$23.73M |
| J2350 |
Injection, ocrelizumab, 1 mg |
483 |
458 |
$13.88M |
| J9271 |
Injection, pembrolizumab, 1 mg |
1,391 |
1,126 |
$12.31M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
3,608 |
3,253 |
$11.72M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
50,569 |
47,716 |
$8.21M |
| 99215 |
Prolong outpt/office vis |
53,588 |
46,984 |
$7.45M |
| J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj |
1,512 |
1,016 |
$6.27M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
38,827 |
36,161 |
$6.03M |
| J9299 |
Injection, nivolumab, 1 mg |
678 |
504 |
$6.02M |
| 36415 |
Collection of venous blood by venipuncture |
495,218 |
234,324 |
$5.66M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
32,899 |
31,347 |
$5.31M |
| G0378 |
Hospital observation service, per hour |
4,707 |
4,540 |
$5.23M |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
1,020 |
983 |
$4.93M |
| 90834 |
Psychotherapy, 45 minutes with patient |
32,537 |
15,089 |
$4.61M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
49,769 |
42,789 |
$4.28M |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
2,431 |
1,466 |
$4.02M |
| J2323 |
Injection, natalizumab, 1 mg |
710 |
667 |
$3.61M |
| 93458 |
|
2,363 |
2,336 |
$3.57M |
| 96415 |
|
9,952 |
8,322 |
$3.56M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
22,649 |
15,559 |
$3.33M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
815 |
593 |
$2.99M |
| 90832 |
Psychotherapy, 30 minutes with patient |
23,669 |
12,641 |
$2.86M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
49,089 |
45,755 |
$2.57M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
11,356 |
5,640 |
$2.04M |
| 80053 |
Comprehensive metabolic panel |
132,109 |
109,640 |
$1.82M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
18,409 |
12,810 |
$1.72M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
15,521 |
13,068 |
$1.72M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
11,735 |
11,614 |
$1.72M |
| J1930 |
Injection, lanreotide, 1 mg |
331 |
309 |
$1.53M |
| 87536 |
|
18,465 |
18,290 |
$1.48M |
| J0485 |
Injection, belatacept, 1 mg |
1,877 |
1,097 |
$1.46M |
| C9600 |
Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch |
852 |
813 |
$1.43M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
8,342 |
8,242 |
$1.39M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
38,517 |
31,355 |
$1.36M |
| 36475 |
|
1,732 |
1,342 |
$1.35M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
54,144 |
45,615 |
$1.35M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
10,427 |
10,352 |
$1.28M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13,735 |
13,371 |
$1.26M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
14,066 |
13,982 |
$1.20M |
| 90945 |
|
21,946 |
1,031 |
$1.16M |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
564 |
414 |
$1.16M |
| 90836 |
|
10,380 |
4,685 |
$1.09M |
| J3357 |
Ustekinumab, for subcutaneous injection, 1 mg |
77 |
73 |
$1.08M |
| J0882 |
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
21,759 |
3,150 |
$1.08M |
| J2501 |
Injection, paricalcitol, 1 mcg |
34,218 |
2,400 |
$1.02M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,762 |
5,560 |
$947K |
| 99205 |
Prolong outpt/office vis |
5,663 |
5,522 |
$937K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,683 |
1,671 |
$912K |
| 93975 |
|
4,221 |
4,026 |
$901K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
1,454 |
1,368 |
$889K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
53,207 |
45,257 |
$876K |
| J9145 |
Injection, daratumumab, 10 mg |
332 |
206 |
$872K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
11,088 |
11,070 |
$861K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
2,390 |
1,620 |
$845K |
| 86900 |
|
40,181 |
31,636 |
$831K |
| 81025 |
|
52,455 |
41,782 |
$779K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
7,152 |
5,370 |
$779K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,194 |
1,191 |
$760K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
612 |
422 |
$755K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
15,801 |
7,007 |
$717K |
| 46607 |
|
916 |
896 |
$716K |
| J0897 |
Injection, denosumab, 1 mg |
485 |
466 |
$699K |
| 80061 |
Lipid panel |
51,753 |
51,085 |
$687K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
2,716 |
2,039 |
$686K |
| 77336 |
|
2,257 |
1,106 |
$655K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
8,886 |
8,853 |
$631K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
24,606 |
18,367 |
$624K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
5,456 |
5,404 |
$604K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
30,025 |
29,445 |
$602K |
| 86901 |
|
40,044 |
31,594 |
$590K |
| C1874 |
Stent, coated/covered, with delivery system |
961 |
935 |
$586K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
5,409 |
5,362 |
$576K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
37,684 |
35,242 |
$569K |
| 93970 |
|
3,804 |
3,766 |
$565K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,256 |
5,131 |
$559K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,660 |
2,580 |
$558K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
2,708 |
2,365 |
$558K |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
2,372 |
278 |
$551K |
| 86480 |
|
10,288 |
10,217 |
$540K |
| J9312 |
Injection, rituximab, 10 mg |
93 |
65 |
$527K |
| 36430 |
|
3,190 |
2,110 |
$520K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
870 |
567 |
$515K |
| 90677 |
|
3,557 |
3,547 |
$505K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
18,068 |
13,675 |
$498K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
13,551 |
10,421 |
$495K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
6,023 |
5,976 |
$495K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
49,051 |
44,332 |
$488K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,472 |
4,397 |
$487K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
8,118 |
3,891 |
$486K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
7,159 |
6,449 |
$484K |
| 54161 |
|
483 |
483 |
$466K |
| J2357 |
Injection, omalizumab, 5 mg |
244 |
174 |
$462K |
| Q5115 |
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg |
319 |
140 |
$439K |
| 86850 |
|
39,848 |
31,437 |
$432K |
| 86361 |
|
13,737 |
13,647 |
$430K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
35,143 |
27,298 |
$426K |
| 88185 |
|
2,721 |
2,268 |
$408K |
| 77386 |
|
1,623 |
165 |
$394K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
258 |
177 |
$390K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
5,880 |
4,956 |
$390K |
| 90651 |
|
5,128 |
5,107 |
$382K |
| 90686 |
|
31,606 |
31,434 |
$381K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
6,258 |
1,336 |
$373K |
| J0791 |
Injection, crizanlizumab-tmca, 5 mg |
100 |
76 |
$372K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
2,886 |
2,161 |
$371K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
52,285 |
47,288 |
$367K |
| 93017 |
|
4,880 |
4,852 |
$363K |
| 96367 |
|
5,704 |
4,022 |
$363K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,206 |
2,087 |
$362K |
| 59025 |
Fetal non-stress test |
3,373 |
2,086 |
$345K |
| J9999 |
Not otherwise classified, antineoplastic drugs |
40 |
27 |
$342K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
3,131 |
3,117 |
$321K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
3,590 |
3,505 |
$318K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,721 |
3,425 |
$308K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
26,326 |
13,541 |
$307K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
86 |
52 |
$302K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
9,960 |
4,624 |
$300K |
| 80050 |
General health panel |
12,366 |
12,089 |
$295K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,755 |
4,373 |
$294K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
1,235 |
934 |
$292K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,748 |
17,961 |
$287K |
| C9062 |
Injection, daratumumab 10 mg and hyaluronidase-fihj |
63 |
39 |
$285K |
| J9022 |
Injection, atezolizumab, 10 mg |
30 |
25 |
$282K |
| 38222 |
|
1,010 |
995 |
$279K |
| 83880 |
|
15,894 |
13,722 |
$277K |
| 49082 |
|
546 |
314 |
$273K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
27,105 |
26,805 |
$269K |
| 97162 |
|
2,669 |
2,655 |
$265K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,157 |
2,131 |
$264K |
| G0008 |
Administration of influenza virus vaccine |
13,195 |
13,182 |
$263K |
| 90791 |
Psychiatric diagnostic evaluation |
1,287 |
1,077 |
$260K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
3,557 |
3,535 |
$260K |
| 82040 |
|
44,880 |
7,111 |
$259K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
2,375 |
2,339 |
$251K |
| 77412 |
|
806 |
92 |
$249K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
3,484 |
3,187 |
$245K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
12,908 |
12,519 |
$243K |
| 92134 |
|
4,141 |
2,866 |
$240K |
| C1760 |
Closure device, vascular (implantable/insertable) |
2,423 |
2,363 |
$239K |
| 88307 |
|
2,133 |
1,811 |
$235K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
3,986 |
3,891 |
$235K |
| 87631 |
|
6,576 |
6,467 |
$233K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
150,745 |
120,056 |
$231K |
| 76641 |
|
4,028 |
3,339 |
$227K |
| 49083 |
|
388 |
243 |
$221K |
| 95819 |
|
688 |
683 |
$220K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
10,457 |
10,438 |
$216K |
| 99385 |
|
1,869 |
1,857 |
$212K |
| 99381 |
|
2,762 |
2,731 |
$211K |
| Q5121 |
Injection, infliximab-axxq, biosimilar, (avsola), 10 mg |
466 |
238 |
$207K |
| J2785 |
Injection, regadenoson, 0.1 mg |
2,412 |
2,393 |
$206K |
| C1888 |
Catheter, ablation, non-cardiac, endovascular (implantable) |
1,926 |
1,098 |
$199K |
| 75574 |
|
1,284 |
1,283 |
$199K |
| J1453 |
Injection, fosaprepitant, 1 mg |
2,496 |
1,662 |
$194K |
| C1769 |
Guide wire |
5,672 |
5,266 |
$192K |
| 90715 |
|
8,482 |
8,457 |
$190K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
3,970 |
3,294 |
$189K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
242 |
85 |
$188K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,466 |
2,383 |
$185K |
| 90671 |
|
1,102 |
1,102 |
$184K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
713 |
696 |
$183K |
| T2022 |
Case management, per month |
1,596 |
1,589 |
$181K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
268 |
261 |
$180K |
| 99443 |
|
2,969 |
2,723 |
$178K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
1,689 |
1,681 |
$178K |
| 93976 |
|
933 |
915 |
$175K |
| 96401 |
|
3,698 |
1,744 |
$175K |
| 93971 |
|
3,496 |
3,327 |
$174K |
| 88341 |
|
2,114 |
2,014 |
$171K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
6,432 |
6,376 |
$171K |
| 77300 |
|
589 |
578 |
$169K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
8,422 |
8,330 |
$168K |
| 76770 |
|
1,209 |
1,199 |
$168K |
| 88342 |
|
5,096 |
4,437 |
$166K |
| 94375 |
|
2,310 |
2,119 |
$165K |
| 19083 |
|
154 |
152 |
$165K |
| 96417 |
|
3,776 |
2,216 |
$162K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
1,399 |
1,192 |
$161K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,595 |
4,451 |
$159K |
| 93356 |
|
1,381 |
1,374 |
$159K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
1,088 |
1,086 |
$158K |
| 97802 |
|
3,300 |
3,265 |
$158K |
| 87522 |
Neg quan hep c or qual rna |
5,051 |
4,911 |
$156K |
| 77334 |
|
679 |
576 |
$155K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,021 |
1,001 |
$154K |
| 77066 |
Tomosynthesis, mammo |
1,628 |
1,614 |
$153K |
| 90670 |
|
8,519 |
8,494 |
$152K |
| 0002A |
|
3,997 |
3,971 |
$149K |
| 11900 |
|
994 |
970 |
$143K |
| 82728 |
|
19,065 |
17,720 |
$140K |
| 17380 |
|
495 |
470 |
$139K |
| 96416 |
|
432 |
240 |
$139K |
| 99386 |
|
1,247 |
1,237 |
$138K |
| 82784 |
|
17,121 |
8,739 |
$138K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
227 |
225 |
$137K |
| J9173 |
Injection, durvalumab, 10 mg |
14 |
12 |
$137K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
1,570 |
1,535 |
$136K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
52,627 |
51,579 |
$136K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
3,463 |
3,116 |
$134K |
| J9070 |
Cyclophosphamide, 100 mg |
529 |
331 |
$132K |
| 36000 |
|
11,250 |
10,898 |
$129K |
| 86769 |
|
4,354 |
4,107 |
$128K |
| 77065 |
Tomosynthesis, mammo |
1,913 |
1,778 |
$127K |
| 99442 |
|
3,158 |
3,006 |
$127K |
| 0001A |
|
3,494 |
3,463 |
$125K |
| 88112 |
|
2,896 |
2,814 |
$124K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,485 |
2,239 |
$123K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,134 |
1,699 |
$123K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
2,414 |
2,290 |
$122K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
51,052 |
44,349 |
$121K |
| 90837 |
Psychotherapy, 53 minutes with patient |
653 |
347 |
$120K |
| 90750 |
|
1,034 |
1,029 |
$120K |
| 80069 |
|
9,026 |
6,476 |
$118K |
| 83655 |
|
9,709 |
9,672 |
$117K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,121 |
1,097 |
$116K |
| 43235 |
|
179 |
178 |
$116K |
| 31575 |
|
524 |
521 |
$116K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,340 |
2,942 |
$114K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
748 |
433 |
$111K |
| 96376 |
|
5,458 |
4,347 |
$111K |
| 93320 |
|
1,074 |
1,062 |
$110K |
| 76937 |
|
1,371 |
1,278 |
$109K |
| 91200 |
|
3,054 |
3,026 |
$107K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
3,849 |
2,439 |
$106K |
| 87507 |
|
895 |
887 |
$105K |
| 76642 |
|
2,207 |
2,123 |
$105K |
| 94060 |
|
928 |
904 |
$104K |
| 86803 |
|
23,259 |
23,019 |
$104K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,569 |
1,303 |
$102K |
| 87799 |
|
2,702 |
1,894 |
$102K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
19,711 |
19,204 |
$102K |
| 17110 |
|
512 |
499 |
$101K |
| 93880 |
|
682 |
675 |
$101K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
7,735 |
6,939 |
$100K |
| 52000 |
|
176 |
176 |
$100K |
| 87497 |
|
3,471 |
2,269 |
$99K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,260 |
2,250 |
$98K |
| 92083 |
|
2,299 |
2,246 |
$98K |
| 90674 |
|
3,829 |
3,824 |
$98K |
| 97165 |
|
1,065 |
1,061 |
$97K |
| 99384 |
|
666 |
630 |
$97K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,253 |
1,244 |
$97K |
| 90732 |
|
1,633 |
1,624 |
$96K |
| 90746 |
|
2,167 |
2,128 |
$95K |
| 83615 |
|
32,725 |
21,914 |
$95K |
| 87517 |
|
2,728 |
2,618 |
$93K |
| 80076 |
|
9,000 |
8,750 |
$93K |
| 76801 |
|
1,525 |
1,440 |
$93K |
| 76813 |
|
1,495 |
1,469 |
$92K |
| 83021 |
|
5,505 |
5,129 |
$92K |
| 88275 |
|
685 |
661 |
$91K |
| 88271 |
|
735 |
708 |
$91K |
| 97803 |
|
2,169 |
2,029 |
$90K |
| 96402 |
|
2,311 |
1,927 |
$90K |
| 76536 |
|
1,196 |
1,183 |
$90K |
| 87428 |
|
4,722 |
4,610 |
$89K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
5,739 |
5,130 |
$89K |
| 83883 |
|
10,960 |
4,780 |
$86K |
| 91320 |
|
1,159 |
1,159 |
$86K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,439 |
2,163 |
$85K |
| 92060 |
|
1,796 |
1,774 |
$84K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,316 |
1,304 |
$82K |
| 85610 |
|
38,158 |
33,395 |
$82K |
| 83735 |
|
32,000 |
21,854 |
$81K |
| C1889 |
Implantable/insertable device, not otherwise classified |
1,919 |
1,856 |
$81K |
| 96411 |
|
1,568 |
1,096 |
$80K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
2,073 |
1,991 |
$79K |
| 83970 |
|
2,521 |
2,431 |
$79K |
| 82248 |
|
45,362 |
36,752 |
$78K |
| 11721 |
|
2,415 |
2,081 |
$78K |
| 93225 |
|
1,191 |
980 |
$78K |
| 82607 |
|
10,609 |
10,236 |
$77K |
| 58100 |
|
341 |
339 |
$75K |
| J0583 |
Injection, bivalirudin, 1 mg |
832 |
812 |
$75K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
6,418 |
6,048 |
$75K |
| 90734 |
|
3,868 |
3,855 |
$74K |
| 84443 |
Thyroid stimulating hormone (TSH) |
22,562 |
21,859 |
$73K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,795 |
3,732 |
$73K |
| G0009 |
Administration of pneumococcal vaccine |
3,388 |
3,385 |
$72K |
| 36591 |
|
1,996 |
1,375 |
$72K |
| J3490 |
Unclassified drugs |
2,637 |
2,362 |
$72K |
| 99402 |
|
1,495 |
1,457 |
$72K |
| 86706 |
|
15,009 |
14,221 |
$71K |
| 92250 |
|
1,818 |
1,797 |
$69K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
2,165 |
2,145 |
$67K |
| 90739 |
|
816 |
812 |
$65K |
| 57454 |
|
220 |
219 |
$65K |
| 82670 |
|
3,702 |
3,649 |
$64K |
| 84403 |
|
4,711 |
4,599 |
$64K |
| 86923 |
|
4,165 |
2,415 |
$61K |
| 97116 |
|
1,854 |
1,041 |
$61K |
| 71046 |
Radiologic examination, chest; 2 views |
17,545 |
16,986 |
$61K |
| 94729 |
|
1,586 |
1,565 |
$61K |
| 99051 |
|
6,445 |
6,276 |
$60K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
653 |
434 |
$60K |
| 92133 |
|
1,818 |
1,714 |
$59K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,011 |
3,704 |
$59K |
| 86780 |
|
24,579 |
24,341 |
$58K |
| 82977 |
|
35,186 |
27,931 |
$57K |
| 88184 |
|
2,171 |
1,939 |
$57K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
46 |
46 |
$56K |
| 70496 |
|
629 |
623 |
$56K |
| 84100 |
|
22,786 |
16,164 |
$55K |
| 99441 |
|
3,180 |
3,029 |
$55K |
| J2796 |
Injection, romiplostim, 10 micrograms |
26 |
13 |
$55K |
| 93925 |
|
380 |
367 |
$55K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
404 |
238 |
$55K |
| 59430 |
|
292 |
291 |
$54K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
137 |
137 |
$53K |
| 86334 |
|
4,743 |
3,903 |
$52K |
| 0124A |
|
1,470 |
1,469 |
$51K |
| 10060 |
|
298 |
295 |
$51K |
| 81002 |
|
46,154 |
35,059 |
$51K |
| 90716 |
|
2,815 |
2,808 |
$51K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
84 |
82 |
$50K |
| 87340 |
|
18,690 |
18,418 |
$50K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
66 |
65 |
$50K |
| 82570 |
|
17,237 |
15,246 |
$50K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
4,039 |
3,882 |
$50K |
| 84550 |
|
19,715 |
11,897 |
$48K |
| 88237 |
|
593 |
585 |
$48K |
| 90620 |
|
1,088 |
1,080 |
$48K |
| 83540 |
|
17,751 |
16,823 |
$48K |
| 77301 |
|
90 |
89 |
$48K |
| 92567 |
|
1,361 |
1,358 |
$47K |
| 94726 |
|
742 |
735 |
$47K |
| 83550 |
|
17,224 |
16,328 |
$47K |
| 11102 |
|
119 |
118 |
$46K |
| 86003 |
|
2,648 |
1,448 |
$46K |
| 0224U |
|
1,201 |
1,197 |
$46K |
| 76830 |
Ultrasound, transvaginal |
2,073 |
2,025 |
$45K |
| 92557 |
|
1,112 |
1,103 |
$45K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
221 |
215 |
$45K |
| 95700 |
|
285 |
282 |
$44K |
| 92015 |
Determination of refractive state |
1,637 |
1,633 |
$44K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,910 |
1,902 |
$43K |
| G0010 |
Administration of hepatitis b vaccine |
2,398 |
2,364 |
$43K |
| 84439 |
|
9,785 |
9,274 |
$43K |
| 90461 |
|
2,246 |
2,240 |
$43K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,651 |
1,614 |
$43K |
| 90707 |
|
2,974 |
2,967 |
$42K |
| J7304 |
Contraceptive supply, hormone containing patch, each |
321 |
318 |
$42K |
| 85027 |
|
27,246 |
24,944 |
$42K |
| 83520 |
|
4,437 |
4,127 |
$42K |
| 85730 |
|
26,109 |
23,256 |
$41K |
| 58300 |
|
404 |
400 |
$40K |
| 88304 |
|
2,822 |
2,608 |
$40K |
| 90694 |
|
1,827 |
1,629 |
$40K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
19,089 |
18,138 |
$40K |
| 0004A |
|
1,070 |
1,069 |
$40K |
| 12001 |
|
190 |
190 |
$39K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
58 |
58 |
$38K |
| 82378 |
|
3,715 |
3,046 |
$37K |
| 83001 |
|
2,730 |
2,704 |
$37K |
| 93308 |
|
294 |
287 |
$37K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,069 |
3,013 |
$37K |
| 99401 |
|
915 |
900 |
$37K |
| 76942 |
|
368 |
361 |
$37K |
| S4993 |
Contraceptive pills for birth control |
4,690 |
4,358 |
$37K |
| 86360 |
|
1,259 |
1,206 |
$37K |
| 86704 |
|
8,455 |
8,266 |
$36K |
| 93226 |
|
626 |
625 |
$36K |
| 82107 |
|
856 |
852 |
$35K |
| 90680 |
|
6,855 |
6,838 |
$35K |
| 90480 |
|
1,186 |
1,184 |
$35K |
| 99417 |
Prolong home eval add 15m |
1,331 |
1,299 |
$35K |
| 88313 |
|
2,667 |
1,990 |
$35K |
| 83002 |
|
2,565 |
2,539 |
$35K |
| 92579 |
|
615 |
612 |
$34K |
| 82043 |
|
11,880 |
11,627 |
$34K |
| 84270 |
|
2,909 |
2,876 |
$34K |
| 84460 |
|
14,653 |
12,090 |
$33K |
| 82150 |
|
8,879 |
6,315 |
$33K |
| 86762 |
|
3,978 |
3,946 |
$33K |
| 86765 |
|
4,081 |
4,058 |
$33K |
| 90678 |
|
167 |
167 |
$33K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
2,147 |
2,096 |
$33K |
| 84702 |
|
11,901 |
10,474 |
$32K |
| 92550 |
|
631 |
625 |
$31K |
| 86870 |
|
1,307 |
1,082 |
$29K |
| 86922 |
|
1,625 |
827 |
$29K |
| 86140 |
|
14,755 |
14,072 |
$28K |
| 95708 |
|
105 |
105 |
$28K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
212 |
211 |
$28K |
| 93242 |
|
470 |
467 |
$27K |
| 93325 |
|
927 |
912 |
$27K |
| 95800 |
|
307 |
306 |
$27K |
| 84146 |
|
1,976 |
1,941 |
$27K |
| 64615 |
|
37 |
37 |
$27K |
| J0741 |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
29 |
28 |
$26K |
| 84165 |
|
6,631 |
5,213 |
$26K |
| 82803 |
|
4,132 |
3,434 |
$26K |
| 86141 |
|
4,096 |
3,820 |
$26K |
| 97542 |
|
434 |
420 |
$26K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
7,090 |
6,962 |
$26K |
| C9399 |
Unclassified drugs or biologicals |
16 |
12 |
$25K |
| 81001 |
|
25,492 |
24,128 |
$25K |
| 90648 |
|
4,795 |
4,791 |
$24K |
| 73562 |
|
2,350 |
2,263 |
$24K |
| 90698 |
|
4,908 |
4,897 |
$24K |
| 90633 |
|
4,683 |
4,679 |
$24K |
| 81206 |
|
194 |
163 |
$24K |
| 80197 |
|
4,191 |
2,513 |
$23K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
783 |
315 |
$23K |
| 73630 |
|
3,142 |
2,930 |
$23K |
| 87070 |
|
5,959 |
5,218 |
$23K |
| 96409 |
|
288 |
180 |
$23K |
| 87480 |
|
2,257 |
2,231 |
$23K |
| 92551 |
|
538 |
477 |
$23K |
| 99383 |
|
245 |
243 |
$23K |
| 87510 |
|
2,246 |
2,223 |
$22K |
| 85045 |
|
11,357 |
8,759 |
$22K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,160 |
1,146 |
$22K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
1,931 |
1,424 |
$22K |
| 87660 |
|
2,207 |
2,186 |
$22K |
| 82533 |
|
2,599 |
2,213 |
$22K |
| 45190 |
|
13 |
13 |
$22K |
| 80051 |
|
2,179 |
2,026 |
$22K |
| 96377 |
|
980 |
720 |
$22K |
| 90656 |
|
2,359 |
2,359 |
$21K |
| 86355 |
|
938 |
916 |
$21K |
| 81003 |
|
21,228 |
20,128 |
$21K |
| 84075 |
|
10,623 |
8,218 |
$21K |
| 73610 |
|
2,496 |
2,208 |
$20K |
| 86787 |
|
3,916 |
3,735 |
$20K |
| 86300 |
|
1,627 |
1,191 |
$19K |
| 59841 |
|
25 |
25 |
$19K |
| 0072A |
|
465 |
465 |
$19K |
| J9045 |
Injection, carboplatin, 50 mg |
615 |
380 |
$19K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,430 |
1,401 |
$19K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
28 |
24 |
$18K |
| 54640 |
|
12 |
12 |
$18K |
| J1750 |
Injection, iron dextran, 50 mg |
101 |
72 |
$18K |
| 92202 |
|
607 |
344 |
$18K |
| 77338 |
|
90 |
89 |
$18K |
| 88173 |
|
480 |
409 |
$18K |
| 73130 |
|
2,644 |
2,405 |
$18K |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
342 |
340 |
$18K |
| 73110 |
|
1,996 |
1,692 |
$17K |
| 85651 |
|
14,808 |
14,056 |
$17K |
| 84402 |
|
1,066 |
1,061 |
$17K |
| 0003A |
|
470 |
470 |
$17K |
| 82105 |
|
4,762 |
4,472 |
$17K |
| 84156 |
|
7,257 |
6,272 |
$16K |
| 84484 |
|
24,696 |
18,001 |
$16K |
| 0071A |
|
423 |
422 |
$16K |
| 99245 |
|
87 |
84 |
$16K |
| 12011 |
|
118 |
118 |
$16K |
| 86160 |
|
2,334 |
1,239 |
$16K |
| 86357 |
|
956 |
932 |
$15K |
| 86359 |
|
864 |
829 |
$15K |
| 96127 |
|
2,622 |
2,590 |
$15K |
| 87077 |
|
5,041 |
4,144 |
$15K |
| J9190 |
Injection, fluorouracil, 500 mg |
705 |
384 |
$15K |
| J1756 |
Injection, iron sucrose, 1 mg |
446 |
187 |
$15K |
| 0358T |
|
505 |
505 |
$15K |
| 96368 |
|
1,173 |
861 |
$15K |
| 73030 |
|
2,147 |
2,029 |
$15K |
| 88360 |
|
335 |
244 |
$15K |
| 84153 |
|
2,882 |
2,757 |
$14K |
| 87902 |
|
54 |
48 |
$14K |
| 36465 |
|
47 |
38 |
$14K |
| 74174 |
|
194 |
189 |
$14K |
| 72100 |
|
1,022 |
1,019 |
$14K |
| 85384 |
|
2,943 |
2,415 |
$14K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
9,505 |
9,194 |
$14K |
| 11982 |
|
66 |
66 |
$14K |
| 86592 |
|
13,805 |
13,611 |
$13K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
10,522 |
9,943 |
$13K |
| 46601 |
|
38 |
37 |
$13K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
1,728 |
1,688 |
$13K |
| 84450 |
|
8,820 |
6,467 |
$13K |
| 90744 |
|
2,894 |
2,889 |
$13K |
| 90723 |
|
2,918 |
2,914 |
$13K |
| 82962 |
|
18,512 |
12,843 |
$12K |
| 70486 |
|
312 |
308 |
$12K |
| 76870 |
|
334 |
328 |
$12K |
| 73560 |
|
1,438 |
1,353 |
$12K |
| D0140 |
Limited oral evaluation - problem focused |
300 |
229 |
$12K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,695 |
1,420 |
$12K |
| 87186 |
|
5,351 |
4,739 |
$12K |
| 82565 |
|
9,440 |
8,625 |
$12K |
| 73502 |
|
1,036 |
1,001 |
$12K |
| 86376 |
|
1,259 |
1,251 |
$12K |
| 95012 |
|
955 |
945 |
$11K |
| 82746 |
|
2,050 |
1,961 |
$11K |
| 97166 |
|
134 |
132 |
$11K |
| 0064A |
|
274 |
274 |
$11K |
| 82950 |
|
2,914 |
2,758 |
$11K |
| 82232 |
|
1,335 |
1,203 |
$11K |
| 86708 |
|
2,478 |
2,460 |
$11K |
| 83010 |
|
1,672 |
1,287 |
$11K |
| 93798 |
|
665 |
141 |
$11K |
| 83690 |
|
19,801 |
18,157 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
6,778 |
5,940 |
$11K |
| 90662 |
|
714 |
626 |
$11K |
| 92555 |
|
193 |
191 |
$10K |
| 85018 |
|
6,831 |
6,642 |
$10K |
| J2704 |
Injection, propofol, 10 mg |
17,845 |
11,697 |
$10K |
| 20610 |
|
78 |
78 |
$10K |
| 87640 |
|
553 |
535 |
$10K |
| 82627 |
|
582 |
580 |
$10K |
| 90710 |
|
1,815 |
1,815 |
$9K |
| 88142 |
|
450 |
447 |
$9K |
| 85378 |
|
3,945 |
3,684 |
$9K |
| 90661 |
|
288 |
288 |
$9K |
| 86200 |
|
1,107 |
1,103 |
$9K |
| 86039 |
|
2,686 |
2,188 |
$9K |
| 86880 |
|
606 |
410 |
$9K |
| 86301 |
|
1,177 |
1,059 |
$9K |
| 82550 |
|
4,020 |
3,675 |
$9K |
| 86735 |
|
1,683 |
1,670 |
$9K |
| 82785 |
|
1,043 |
1,010 |
$8K |
| 87081 |
|
2,254 |
2,237 |
$8K |
| 90378 |
|
28 |
27 |
$8K |
| 82247 |
|
11,688 |
8,934 |
$8K |
| 95249 |
|
146 |
145 |
$8K |
| 0081A |
|
183 |
183 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
3,853 |
3,697 |
$8K |
| 73590 |
|
1,526 |
1,410 |
$8K |
| 99201 |
|
93 |
93 |
$8K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
6,062 |
4,195 |
$8K |
| 11720 |
|
269 |
269 |
$8K |
| 86800 |
|
884 |
816 |
$7K |
| 0082A |
|
162 |
161 |
$7K |
| 86235 |
|
1,457 |
838 |
$7K |
| 87641 |
|
424 |
412 |
$7K |
| 0054A |
|
182 |
182 |
$7K |
| 90700 |
|
1,849 |
1,849 |
$7K |
| 90632 |
|
154 |
154 |
$7K |
| 90696 |
|
1,792 |
1,792 |
$7K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
6,105 |
3,308 |
$7K |
| 87653 |
|
291 |
287 |
$7K |
| 88311 |
|
910 |
854 |
$7K |
| 87210 |
|
3,046 |
2,910 |
$7K |
| 0154A |
|
152 |
152 |
$7K |
| G9012 |
Other specified case management service not elsewhere classified |
76 |
73 |
$7K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
38 |
38 |
$7K |
| J9075 |
Injection, cyclophosphamide, not otherwise specified, 5 mg |
42 |
26 |
$7K |
| 36246 |
|
14 |
13 |
$6K |
| 93750 |
|
168 |
155 |
$6K |
| Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram |
69 |
44 |
$6K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
72 |
27 |
$6K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
97 |
90 |
$6K |
| 72082 |
|
117 |
116 |
$6K |
| 76775 |
|
133 |
132 |
$6K |
| 80074 |
|
434 |
429 |
$6K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,323 |
2,358 |
$6K |
| 84305 |
|
360 |
355 |
$6K |
| 82542 |
|
400 |
385 |
$6K |
| 87040 |
|
7,224 |
4,487 |
$6K |
| 70498 |
|
451 |
447 |
$6K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,389 |
2,324 |
$6K |
| 86905 |
|
262 |
157 |
$6K |
| 76882 |
|
202 |
198 |
$6K |
| 81267 |
|
47 |
37 |
$6K |
| C1781 |
Mesh (implantable) |
98 |
97 |
$5K |
| C1876 |
Stent, non-coated/non-covered, with delivery system |
12 |
12 |
$5K |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
1,168 |
949 |
$5K |
| 76857 |
|
263 |
258 |
$5K |
| 88108 |
|
153 |
133 |
$5K |
| 86701 |
|
803 |
790 |
$5K |
| 82677 |
|
408 |
408 |
$5K |
| 93922 |
|
129 |
128 |
$5K |
| 99153 |
Mod sedat endo service >5yrs |
2,679 |
2,623 |
$5K |
| 81207 |
|
61 |
38 |
$5K |
| 85245 |
|
356 |
284 |
$5K |
| D9223 |
Deep sedation/general anesthesia - each subsequent 15 minute increment |
29 |
29 |
$5K |
| 84425 |
|
579 |
567 |
$5K |
| 92020 |
|
124 |
124 |
$5K |
| 73090 |
|
1,191 |
1,042 |
$5K |
| 92201 |
|
116 |
88 |
$5K |
| 75716 |
|
78 |
76 |
$5K |
| 84480 |
|
1,303 |
1,263 |
$5K |
| 81374 |
|
91 |
91 |
$5K |
| 86665 |
|
384 |
304 |
$5K |
| 82397 |
|
659 |
632 |
$5K |
| 88160 |
|
237 |
226 |
$5K |
| 92002 |
|
51 |
51 |
$5K |
| 11981 |
|
27 |
27 |
$5K |
| 86644 |
|
530 |
497 |
$5K |
| 72170 |
|
513 |
507 |
$5K |
| 86431 |
|
1,516 |
1,508 |
$4K |
| 73070 |
|
764 |
681 |
$4K |
| S0028 |
Injection, famotidine, 20 mg |
7,346 |
6,284 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
11,366 |
9,576 |
$4K |
| D9222 |
|
29 |
29 |
$4K |
| 88300 |
|
561 |
541 |
$4K |
| 85240 |
|
411 |
328 |
$4K |
| 82310 |
|
3,221 |
3,132 |
$4K |
| D0330 |
Panoramic radiographic image |
134 |
134 |
$4K |
| 58301 |
|
40 |
40 |
$4K |
| 95816 |
|
14 |
14 |
$4K |
| 95886 |
|
53 |
53 |
$4K |
| 86696 |
|
522 |
505 |
$4K |
| A4648 |
Tissue marker, implantable, any type, each |
432 |
416 |
$4K |
| 85246 |
|
358 |
286 |
$4K |
| 72131 |
|
106 |
106 |
$4K |
| J9370 |
Vincristine sulfate, 1 mg |
402 |
272 |
$4K |
| 83605 |
|
6,963 |
5,742 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,959 |
4,465 |
$4K |
| 10005 |
|
16 |
15 |
$3K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
119 |
93 |
$3K |
| 82024 |
|
105 |
104 |
$3K |
| 92587 |
|
154 |
154 |
$3K |
| 87338 |
|
600 |
593 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
5,704 |
3,933 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,949 |
4,768 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
6,501 |
6,027 |
$3K |
| J9171 |
Injection, docetaxel, 1 mg |
35 |
24 |
$3K |
| 87205 |
|
4,088 |
2,625 |
$3K |
| 99152 |
|
3,056 |
2,993 |
$3K |
| 83519 |
|
343 |
326 |
$3K |
| 88262 |
|
36 |
36 |
$3K |
| 96523 |
|
71 |
58 |
$3K |
| 86225 |
|
919 |
905 |
$3K |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
589 |
329 |
$3K |
| 88720 |
|
1,383 |
987 |
$3K |
| 76514 |
|
98 |
97 |
$3K |
| 84166 |
|
581 |
516 |
$3K |
| 86580 |
|
347 |
336 |
$3K |
| C1893 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
70 |
69 |
$3K |
| 84163 |
|
277 |
271 |
$3K |
| 73700 |
|
27 |
26 |
$3K |
| 84520 |
|
8,707 |
7,887 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13,683 |
13,277 |
$3K |
| J1380 |
Injection, estradiol valerate, up to 10 mg |
709 |
443 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
17,803 |
15,530 |
$3K |
| 76820 |
|
131 |
59 |
$3K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
2,967 |
2,533 |
$3K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
15 |
15 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
106 |
68 |
$3K |
| 82947 |
|
5,781 |
5,209 |
$3K |
| 84132 |
|
4,753 |
4,116 |
$3K |
| 86147 |
|
271 |
141 |
$3K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
2,791 |
2,739 |
$3K |
| 86255 |
|
900 |
873 |
$3K |
| 86593 |
|
6,787 |
6,539 |
$3K |
| 84295 |
|
6,432 |
5,708 |
$3K |
| 76604 |
|
148 |
144 |
$2K |
| 86777 |
|
339 |
327 |
$2K |
| 88172 |
|
62 |
59 |
$2K |
| D1110 |
Prophylaxis - adult |
58 |
58 |
$2K |
| 88312 |
|
124 |
97 |
$2K |
| 96380 |
|
111 |
111 |
$2K |
| 92582 |
|
25 |
25 |
$2K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
360 |
279 |
$2K |
| 62270 |
|
14 |
12 |
$2K |
| 82108 |
|
65 |
15 |
$2K |
| 83695 |
|
247 |
247 |
$2K |
| 74018 |
|
477 |
457 |
$2K |
| 82985 |
|
438 |
435 |
$2K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
15 |
15 |
$2K |
| 91318 |
|
39 |
39 |
$2K |
| 97167 |
|
25 |
25 |
$2K |
| C1753 |
Catheter, intravascular ultrasound |
26 |
25 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
545 |
531 |
$2K |
| 82103 |
|
282 |
280 |
$2K |
| 82610 |
|
208 |
201 |
$2K |
| 82553 |
|
1,708 |
1,179 |
$2K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
13 |
13 |
$2K |
| 99173 |
|
449 |
448 |
$2K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,515 |
2,454 |
$2K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
24 |
13 |
$2K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
286 |
285 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14,695 |
13,046 |
$2K |
| 86336 |
|
423 |
423 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
1,558 |
1,141 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,724 |
1,468 |
$2K |
| 90381 |
|
75 |
75 |
$2K |
| 86304 |
|
182 |
155 |
$2K |
| 97161 |
|
28 |
28 |
$2K |
| 75625 |
|
52 |
51 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,303 |
1,287 |
$2K |
| 0012A |
|
44 |
44 |
$2K |
| 99421 |
|
24 |
24 |
$2K |
| 89051 |
|
1,890 |
1,378 |
$2K |
| 92611 |
|
12 |
12 |
$2K |
| 90653 |
|
158 |
158 |
$2K |
| 95957 |
|
14 |
12 |
$2K |
| 82330 |
|
1,668 |
1,437 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,729 |
3,446 |
$2K |
| 70491 |
|
14 |
14 |
$2K |
| 1036F |
|
39,793 |
35,407 |
$2K |
| 84481 |
|
293 |
265 |
$2K |
| 86707 |
|
319 |
319 |
$1K |
| 82435 |
|
5,982 |
5,551 |
$1K |
| 51701 |
|
13 |
13 |
$1K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,267 |
859 |
$1K |
| 77062 |
|
12 |
12 |
$1K |
| 77061 |
|
12 |
12 |
$1K |
| C1773 |
Retrieval device, insertable (used to retrieve fractured medical devices) |
38 |
37 |
$1K |
| 91321 |
|
37 |
37 |
$1K |
| 84445 |
|
30 |
30 |
$1K |
| 90474 |
|
111 |
110 |
$1K |
| 73060 |
|
259 |
243 |
$1K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
153 |
59 |
$1K |
| 87350 |
|
298 |
298 |
$1K |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
58 |
39 |
$1K |
| 97163 |
|
13 |
13 |
$1K |
| 82374 |
|
3,993 |
3,741 |
$1K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,592 |
1,158 |
$1K |
| 85597 |
|
79 |
79 |
$1K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
15 |
14 |
$1K |
| 76885 |
|
13 |
13 |
$1K |
| 71250 |
|
16 |
16 |
$1K |
| 73140 |
|
203 |
186 |
$1K |
| 73600 |
|
140 |
133 |
$1K |
| 90611 |
|
201 |
201 |
$1K |
| 91319 |
|
15 |
15 |
$1K |
| 85347 |
|
1,852 |
1,586 |
$1K |
| 73552 |
|
177 |
168 |
$1K |
| 10061 |
|
12 |
12 |
$1K |
| 87652 |
|
66 |
64 |
$1K |
| 99397 |
|
12 |
12 |
$1K |
| 93799 |
|
490 |
363 |
$1K |
| 84681 |
|
68 |
58 |
$994.72 |
| 84155 |
|
4,757 |
4,626 |
$983.12 |
| D1120 |
Prophylaxis - child |
28 |
28 |
$981.08 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
2,805 |
2,733 |
$957.31 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
379 |
286 |
$954.27 |
| 85670 |
|
263 |
251 |
$948.81 |
| D0274 |
Bitewings - four radiographic images |
40 |
40 |
$940.68 |
| 87899 |
|
237 |
211 |
$930.25 |
| 99382 |
|
12 |
12 |
$928.76 |
| 88302 |
|
111 |
108 |
$924.18 |
| OP250 |
|
471 |
282 |
$919.54 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
330 |
328 |
$900.39 |
| 83921 |
|
78 |
77 |
$897.22 |
| 0011A |
|
21 |
21 |
$881.80 |
| 92025 |
|
14 |
14 |
$828.35 |
| J3480 |
Injection, potassium chloride, per 2 meq |
799 |
458 |
$817.91 |
| 83498 |
|
40 |
37 |
$815.10 |
| J9206 |
Injection, irinotecan, 20 mg |
43 |
24 |
$771.92 |
| 80177 |
|
224 |
214 |
$735.95 |
| 86038 |
|
279 |
247 |
$735.89 |
| 95885 |
|
12 |
12 |
$718.26 |
| 82960 |
|
401 |
392 |
$712.28 |
| 83051 |
|
297 |
254 |
$704.62 |
| 86356 |
|
90 |
50 |
$701.33 |
| 84466 |
|
95 |
94 |
$692.33 |
| 82390 |
|
140 |
138 |
$674.52 |
| 91308 |
|
401 |
387 |
$665.67 |
| 69210 |
|
12 |
12 |
$646.99 |
| 90380 |
|
51 |
51 |
$641.48 |
| C1819 |
Surgical tissue localization and excision device (implantable) |
41 |
40 |
$635.36 |
| 0052A |
|
15 |
15 |
$634.46 |
| 84145 |
|
360 |
342 |
$622.97 |
| 99188 |
|
106 |
106 |
$615.77 |
| 80145 |
|
63 |
61 |
$614.05 |
| D0120 |
Periodic oral evaluation - established patient |
18 |
12 |
$600.33 |
| 86705 |
|
150 |
148 |
$595.19 |
| 76818 |
|
15 |
14 |
$587.44 |
| 76812 |
|
13 |
13 |
$586.87 |
| J9267 |
Injection, paclitaxel, 1 mg |
34 |
12 |
$581.92 |
| D9430 |
|
33 |
29 |
$557.60 |
| 86828 |
|
13 |
12 |
$554.28 |
| 87535 |
|
30 |
30 |
$552.49 |
| 73080 |
|
51 |
45 |
$545.89 |
| 72110 |
|
25 |
25 |
$544.07 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,660 |
2,870 |
$539.66 |
| 84154 |
|
121 |
120 |
$520.30 |
| C8930 |
Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision |
24 |
24 |
$510.89 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,890 |
3,550 |
$508.12 |
| 93351 |
|
14 |
14 |
$503.45 |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
28 |
13 |
$501.06 |
| 83525 |
|
49 |
37 |
$491.49 |
| 90682 |
|
22 |
22 |
$478.49 |
| 11056 |
|
12 |
12 |
$474.41 |
| 86778 |
|
57 |
55 |
$471.07 |
| 87102 |
|
198 |
175 |
$464.19 |
| 51702 |
|
15 |
14 |
$458.94 |
| 83516 |
|
20 |
12 |
$458.50 |
| 86688 |
|
67 |
64 |
$454.72 |
| 85613 |
|
85 |
78 |
$451.51 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
7,117 |
5,975 |
$438.50 |
| 86146 |
|
50 |
26 |
$438.08 |
| 82172 |
|
40 |
40 |
$427.31 |
| 99406 |
|
12 |
12 |
$399.12 |
| 73564 |
|
12 |
12 |
$397.69 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
12 |
12 |
$396.12 |
| 86645 |
|
78 |
75 |
$383.07 |
| 87206 |
|
357 |
239 |
$382.30 |
| 86695 |
|
56 |
56 |
$381.67 |
| 76810 |
|
33 |
33 |
$381.12 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
268 |
220 |
$372.00 |
| 82810 |
|
293 |
274 |
$365.29 |
| D0220 |
Intraoral - periapical first radiographic image |
43 |
42 |
$362.24 |
| 94010 |
|
13 |
13 |
$357.28 |
| 82955 |
|
67 |
67 |
$347.05 |
| 80164 |
|
93 |
91 |
$342.70 |
| 99415 |
Prolong outpt/office vis |
88 |
82 |
$338.24 |
| 80321 |
|
81 |
77 |
$330.75 |
| 87324 |
|
105 |
104 |
$328.97 |
| 87075 |
|
179 |
171 |
$301.92 |
| 4004F |
|
11,378 |
10,271 |
$290.98 |
| 86687 |
|
67 |
64 |
$286.16 |
| 92136 |
|
12 |
12 |
$271.76 |
| 90647 |
|
55 |
55 |
$268.29 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
904 |
878 |
$264.39 |
| 84260 |
|
14 |
13 |
$264.15 |
| 91312 |
|
1,166 |
1,163 |
$256.99 |
| 81268 |
|
48 |
37 |
$250.36 |
| A0425 |
Ground mileage, per statute mile |
31 |
29 |
$243.89 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
5,630 |
4,789 |
$236.39 |
| 80195 |
|
39 |
24 |
$230.19 |
| 84157 |
|
140 |
124 |
$227.96 |
| 86709 |
|
54 |
53 |
$227.77 |
| J7509 |
Methylprednisolone oral, per 4 mg |
88 |
55 |
$221.75 |
| 76814 |
|
17 |
16 |
$209.89 |
| 99408 |
|
14 |
14 |
$209.70 |
| 87116 |
|
133 |
119 |
$209.47 |
| 82085 |
|
30 |
29 |
$203.40 |
| 84300 |
|
203 |
196 |
$199.94 |
| 82575 |
|
68 |
55 |
$195.02 |
| 90713 |
|
12 |
12 |
$194.02 |
| 84207 |
|
12 |
12 |
$191.00 |
| 87449 |
|
228 |
222 |
$185.52 |
| 90685 |
|
24 |
24 |
$177.11 |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
15 |
12 |
$164.56 |
| 86328 |
|
24 |
24 |
$162.95 |
| 72070 |
|
17 |
17 |
$158.96 |
| 76512 |
|
14 |
13 |
$156.45 |
| 86682 |
|
26 |
26 |
$156.17 |
| 82951 |
|
25 |
25 |
$150.48 |
| 87220 |
|
126 |
113 |
$147.73 |
| 82945 |
|
87 |
77 |
$137.55 |
| D0230 |
Intraoral - periapical each additional radiographic image |
26 |
26 |
$133.72 |
| C1729 |
Catheter, drainage |
28 |
28 |
$131.87 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
108 |
104 |
$131.84 |
| 85520 |
|
16 |
13 |
$129.28 |
| J1940 |
Injection, furosemide, up to 20 mg |
639 |
472 |
$127.88 |
| J1245 |
Injection, dipyridamole, per 10 mg |
24 |
24 |
$127.86 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
309 |
296 |
$126.80 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
155 |
142 |
$120.69 |
| 84134 |
|
25 |
25 |
$118.24 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
6,126 |
4,687 |
$118.23 |
| S0030 |
Injection, metronidazole, 500 mg |
389 |
326 |
$117.30 |
| 71100 |
|
98 |
97 |
$112.57 |
| 85014 |
|
651 |
575 |
$112.25 |
| 84311 |
|
195 |
173 |
$103.93 |
| J9250 |
Methotrexate sodium, 5 mg |
72 |
54 |
$103.57 |
| 80143 |
|
162 |
155 |
$102.89 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
35 |
28 |
$90.42 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
165 |
124 |
$90.24 |
| 82952 |
|
104 |
100 |
$88.11 |
| J2060 |
Injection, lorazepam, 2 mg |
606 |
533 |
$86.16 |
| J1630 |
Injection, haloperidol, up to 5 mg |
858 |
766 |
$84.91 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
167 |
160 |
$83.78 |
| D9310 |
|
13 |
12 |
$83.59 |
| 74019 |
|
12 |
12 |
$82.20 |
| 80179 |
|
134 |
130 |
$82.05 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
2,508 |
2,180 |
$81.50 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
195 |
191 |
$81.11 |
| H0049 |
Alcohol and/or drug screening |
15 |
15 |
$72.72 |
| 73620 |
|
28 |
26 |
$61.99 |
| 81257 |
|
15 |
15 |
$61.36 |
| 83993 |
|
14 |
14 |
$56.40 |
| 84133 |
|
38 |
38 |
$56.19 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
12 |
12 |
$53.08 |
| 87430 |
|
13 |
12 |
$52.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
155 |
95 |
$51.52 |
| 91307 |
|
860 |
793 |
$51.14 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
26 |
24 |
$51.02 |
| 83050 |
|
62 |
52 |
$50.57 |
| 80320 |
|
377 |
364 |
$47.54 |
| 87254 |
|
12 |
12 |
$47.32 |
| 82375 |
|
39 |
38 |
$42.63 |
| 82465 |
|
12 |
12 |
$35.21 |
| 84436 |
|
12 |
12 |
$34.20 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
13 |
13 |
$28.70 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
19 |
14 |
$28.17 |
| 84478 |
|
13 |
13 |
$25.15 |
| 83935 |
|
12 |
12 |
$21.39 |
| 91305 |
|
183 |
180 |
$20.19 |
| 91306 |
|
120 |
119 |
$19.04 |
| 82948 |
|
131 |
125 |
$19.00 |
| 80329 |
|
134 |
68 |
$17.98 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
5,710 |
4,939 |
$16.98 |
| 91300 |
|
3,593 |
3,291 |
$14.01 |
| J1836 |
Injection, metronidazole, 10 mg |
70 |
65 |
$9.85 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
17 |
16 |
$9.53 |
| 82436 |
|
12 |
12 |
$7.43 |
| 87176 |
|
21 |
12 |
$6.40 |
| J1598 |
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg |
87 |
83 |
$6.14 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
12 |
12 |
$3.11 |
| J7510 |
Prednisolone oral, per 5 mg |
63 |
62 |
$2.98 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
115 |
108 |
$2.59 |
| 91317 |
|
15 |
15 |
$2.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
38 |
37 |
$1.98 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
103 |
102 |
$0.64 |
| C9113 |
Injection, pantoprazole sodium, per vial |
20 |
16 |
$0.57 |
| G9740 |
Hospice services given to patient any time during the measurement period |
193 |
158 |
$0.46 |
| G9687 |
Hospice services provided to patient any time during the measurement period |
306 |
281 |
$0.43 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
20 |
20 |
$0.17 |
| 3078F |
|
4,043 |
3,862 |
$0.11 |
| G9691 |
Patient had hospice services any time during the measurement period |
24 |
20 |
$0.10 |
| 3074F |
|
3,373 |
3,249 |
$0.09 |
| 3077F |
|
1,047 |
1,002 |
$0.08 |
| 3080F |
|
244 |
235 |
$0.04 |
| 3079F |
|
584 |
563 |
$0.02 |
| 3044F |
|
1,206 |
1,181 |
$0.01 |
| 3048F |
|
1,507 |
1,452 |
$0.01 |
| 3049F |
|
436 |
415 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,546 |
1,360 |
$0.00 |
| 91315 |
|
130 |
130 |
$0.00 |
| 99429 |
|
3,433 |
2,049 |
$0.00 |
| 3075F |
|
467 |
455 |
$0.00 |
| 1111F |
|
165 |
139 |
$0.00 |
| G8756 |
No documentation of blood pressure measurement, reason not given |
279 |
267 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
129 |
118 |
$0.00 |
| D1310 |
|
17 |
17 |
$0.00 |
| 1123F |
|
416 |
346 |
$0.00 |
| G9231 |
Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period |
153 |
128 |
$0.00 |
| 0503F |
|
17 |
17 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
12 |
12 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
12 |
12 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
16 |
12 |
$0.00 |
| 81599 |
|
15 |
15 |
$0.00 |
| 91301 |
|
12 |
12 |
$0.00 |
| 3051F |
|
52 |
52 |
$0.00 |
| 99080 |
|
10,720 |
1,674 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
523 |
487 |
$0.00 |
| G8938 |
Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible |
1,790 |
1,381 |
$0.00 |
| 3050F |
|
484 |
472 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,177 |
1,055 |
$0.00 |
| 3046F |
|
53 |
52 |
$0.00 |
| 4040F |
|
82 |
75 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
13 |
13 |
$0.00 |
| 93571 |
|
24 |
24 |
$0.00 |
| 3725F |
|
12 |
12 |
$0.00 |
| 3045F |
|
36 |
35 |
$0.00 |